Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Rezulin receives FDA marketing clearance for type 2 diabetes

Aug. 5, 1997

Sibutramine: New hope for obese patients

Aug. 5, 1997

Bioniche to manufacture Orphan Medical's Intrachol

Aug. 5, 1997

U.S. patent issues for bone substitute technology

Aug. 5, 1997

Insulin mediator isolated from beef liver

Aug. 5, 1997

Alteon's pimagedine progresses to phase III

Aug. 4, 1997

Crinone approved in U.S. for additional indication

Aug. 4, 1997

Ergoset improves metabolism in healthy obese women

Aug. 4, 1997

Novartis reports new NPY antagonists with selectivity for Y5 receptors

Aug. 1, 1997

Clinical trial of Lipitor for the reduction of cholesterol in women

July 31, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...